The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Market Value Of The Cell And Gene Therapy Contract Research Organization Market Projected To Expand During 2026–2030?

The cell and gene therapy contract research organization market has seen rapid growth in recent years. It will grow from $6.92 billion in 2025 to $7.76 billion in 2026 at a compound annual growth rate (CAGR) of 12.1%. The market’s historical expansion is attributable to an increasing number of early-stage cell and gene therapy programs, limited in-house development capabilities, a rise in rare disease research pipelines, growing regulatory complexity within advanced therapies, and an increasing reliance on external research expertise.

The market size for cell and gene therapy contract research organizations is projected to experience swift expansion over the coming years. This market is anticipated to reach $12.36 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 12.3%. Factors contributing to this growth during the forecast period include heightened clinical trial activity in gene therapies, the broadening of personalized medicine development, increased investments in oncology and genetic disorder research, a rising need for accelerated development timelines, and enhanced collaboration between biotechnology companies and CROs. Key trends observed over the forecast period encompass an increase in outsourcing for cell and gene therapy research, a surging demand for integrated preclinical and clinical services, a heightened emphasis on regulatory and compliance expertise, the expansion of support for vector development and manufacturing, and improved utilization of data-driven trial management strategies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33057&type=smp

Which Significant Factors Are Encouraging Growth In The Cell And Gene Therapy Contract Research Organization Market?

The increasing emphasis on personalized medicine and targeted therapeutics is anticipated to drive expansion in the cell and gene therapy contract research organization (CRO) market moving ahead. This approach entails creating treatments specifically adapted to an individual’s unique genetic, molecular, or cellular profile to enhance effectiveness and minimize side effects. The heightened attention on personalized medicine stems from regulators and healthcare systems increasingly favoring precision therapies to tackle intricate diseases and attain improved clinical outcomes. Cell and gene therapy contract research organizations (CROs) facilitate personalized medicine through their specialized preclinical, clinical, and regulatory services essential for the development, testing, and validation of intricate gene- and cell-based therapeutic products. As an illustration, in April 2025, the Personalized Medicine Coalition, a US-based nonprofit, reported that the Food and Drug Administration (FDA) approved 18 personalized medicines during 2024, representing approximately 38% of all newly approved therapeutic molecular entities. Consequently, the expanding focus on personalized medicine and targeted therapeutics is a significant factor boosting the cell and gene therapy contract research organization (CRO) market.

How Are Different Segment Groups Identified Within The Cell And Gene Therapy Contract Research Organization Market?

The cell and gene therapy contract research organization market covered in this report is segmented –

1) By Type: Preclinical Contract Research Organization; Clinical Stage Contract Research Organization; Other Types

2) By Service: Project And Clinical Trial Management; Regulatory Strategy; Data Management And Medical Writing; Clinical Monitoring; Quality Management And Good Manufacturing Practice Compliance; Biostatistics And Safety Monitoring; Patient And Site Recruitment; Technology Transfer; Other Services

3) By Indication: Oncology; Central Nervous System Disorders; Infectious Diseases; Immunological Disorders; Cardiovascular Diseases; Respiratory Diseases; Diabetes; Ophthalmology; Pain Management; Other Indications

4) By Modality: Cell-Based Therapies; Gene Therapies; Gene-Modified Cell Therapies

5) By Application: Hospital; Research Institute; Other Applications

Subsegments:

1) By Preclinical Contract Research Organization: In Vitro Testing Services; In Vivo Animal Model Services; Toxicology And Safety Assessment; Other Preclinical Services

2) By Clinical Stage Contract Research Organization: Phase I Clinical Trial Services; Phase II Clinical Trial Services; Phase III Clinical Trial Services; Other Clinical Stage Services

3) By Other Types: Regulatory Consulting Services; Process Development Services; Manufacturing Support Services; Other Support Services

Which Trends Are Influencing The Direction Of The Cell And Gene Therapy Contract Research Organization Market?

Major companies within the cell and gene therapy contract research organization (CRO) market are concentrating on developing innovative solutions, such as expanded laboratory and analytical services. These efforts aim to enhance the efficiency of therapy development, ensure regulatory compliance, and improve research precision by offering state-of-the-art facilities, specialized equipment, and integrated testing capabilities for cell and gene therapies. Expanded laboratory and analytical services refer to contract research organization (CRO) offerings that increase capacity, enable the execution of complex assays, and provide sponsors with end-to-end support for the development of advanced cell and gene therapies. For instance, in August 2025, Labcorp Holdings Inc., a US-based healthcare company, enlarged its cell and gene therapy laboratory in Madison, Wisconsin, thereby improving its capabilities for cell characterization, vector analytics, and regulatory-compliant testing. This expanded facility now provides specialized infrastructure for intricate cell and gene therapy workflows, supports high-throughput sample processing, and integrates advanced analytical platforms, positioning it as a comprehensive solution for accelerating cell and gene therapy research and development.

Who Are The Key Market Participants In The Cell And Gene Therapy Contract Research Organization Market?

Major companies operating in the cell and gene therapy contract research organization market are Thermo Fisher Scientific Inc., IQVIA Holdings Inc., Laboratory Corporation of America Holdings (Labcorp), ICON plc, WuXi AppTec Co. Ltd., Syneos Health Inc., Charles River Laboratories International Inc., Parexel International Corporation, Fortrea Holdings Inc., CMIC Co. Ltd., Medpace Holdings Inc., PharmaLex GmbH, Premier Research International LLC, Worldwide Clinical Trials Inc., Novotech (Australia) Pty Ltd., Precision for Medicine Inc., Syngene International Limited, Allucent Inc., TFS HealthScience AB, QPS Holdings LLC, Altasciences Company Inc., Veristat LLC, Linical Co. Ltd., Aixial Group, ProRelix Research LLC

Access The Complete Cell And Gene Therapy Contract Research Organization Market Report:

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-contract-research-organization-market-report

Which Region Leads The Cell And Gene Therapy Contract Research Organization Market By Size?

North America was the largest region in the cell and gene therapy contract research organization (CRO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy contract research organization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Cell And Gene Therapy Contract Research Organization Market Report for Deeper Competitive Insights

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model